Stem cell biotechnology company Cynata Therapeutics has started clinical trials with an initial cohort of patients in Adelaide of its patented product, aimed at treating diabetic foot ulcers.
[Cynata Therapeutics (The West Australian)]
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Brought to you by
